Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
The top July 4 fireworks, festivals, and food trucks in the Triangle + Maps
Recommended
Q&A: Preparing dogs for summertime heat
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GSK plc
Recent news which mentions GSK plc
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
Tags
Vaccinations
Health care industry
Peloton Interactive Inc
From
CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
June 17, 2024
Tags
Health care industry
Pfizer Inc
Merck & Co Inc
From
CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
Tags
Breaking news
Business
Pharmaceuticals
From
CNBC.com News
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
June 03, 2024
Tags
Breaking News: Markets
World Markets
Sanofi SA
From
CNBC.com News
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
May 31, 2024
Tags
Health care industry
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Moderna says FDA delayed RSV vaccine approval to end of May
May 10, 2024
Tags
Health care industry
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
Tags
Biotechnology
GSK plc
AstraZeneca PLC
From
CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
April 09, 2024
Tags
Health care industry
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
March 26, 2024
Tags
Healthy Returns
Health care industry
AstraZeneca PLC
From
CNBC.com News
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
February 29, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Retail industry
Breaking News: Investing
Breaking News: Markets
From
CNBC.com News
Cramer's Lightning Round: 'Hold off' on Kroger
February 05, 2024
Tags
S&P 500
Mad Money
Parker/Hannifin Corp
From
CNBC.com News
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
January 31, 2024
Tags
Biotechnology
GSK plc
US: News
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Alphabet Inc
Johnson & Johnson
Microsoft Corp
From
CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
Tags
Sanofi SA
Breaking news
Business
From
CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
October 04, 2023
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Health care industry
From
CNBC.com News
Covid, RSV and flu vaccines are now available — here's how to decide whether to get them together
September 15, 2023
Tags
Breaking news
Business
Pharmaceuticals
From
CNBC.com News
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
September 13, 2023
Tags
Health care industry
Flu
Biotech and Pharmaceuticals
From
CNBC.com News
Covid vaccine rollout begins early in the UK with new variant under watch
September 11, 2023
Tags
Health care industry
Coronavirus
Europe Markets
From
CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
August 10, 2023
Tags
AstraZeneca PLC
Biotechnology
GSK plc
From
CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
August 02, 2023
Tags
Spin/offs
Business News
Health & Science
From
CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
Tags
Biotech and Pharmaceuticals
Vaccinations
Health care industry
From
CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
June 29, 2023
Tags
Social issues
Respiratory syncytial virus
GSK plc
From
CNBC.com News
Stocks making the biggest moves midday: Starbucks, CarMax, Virgin Galactic and more
June 23, 2023
Tags
Economy
GSK plc
Virgin Galactic Holdings Inc
From
CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
Tags
Companies
US: News
Respiratory syncytial virus
From
CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
June 21, 2023
Tags
Regulations
Vaccinations
Health care industry
From
CNBC.com News
Stocks making the biggest moves midday: Dollar Tree, Amazon, FedEx and more
June 21, 2023
Tags
Coinbase Global Inc
Dollar Tree Inc
BlackRock Inc
From
CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
June 21, 2023
Tags
Vaccinations
Health care industry
Vaccine controversy
From
CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
June 21, 2023
Tags
Breaking news
Business
Pharmaceuticals
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.